If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 2 of 2
Standardizing Treatments for Pulmonary Exacerbations: A Platform for Evaluating Treatment Decisions to Improve Outcomes (STOP360) Aminoglycoside Study (AG Study)
Objective
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study (STOP360AG)
Protocol No
PULM-CFF-STOP360AG
Categories
A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY Study)
Objective
The AIRTIVITY Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Protocol No
PULM-BOEHRINGER-AIRTIVITY
Categories